Diversity in Biopharma Leadership Makes Dollars and Sense

A series of recent studies examining diversity and financial performance have fueled a growing insistence among big-name private equity firms, pension funds and money managers that their investees hire and promote more diverse talent up the ranks – or risk losing their clients’ capital.
BIO launched a Workforce Development, Diversity and Inclusion (WDDI) Initiative last year, and a key part of our initial push has been to study and communicate the business case for diversity to the b